​Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

Document Type

Presentation

Publication Date

2021

Publication Title

SITC 2021

Keywords

oregon; washington

Clinical Institute

Cancer

Clinical Institute

Women & Children

Department

Oncology

This document is currently not available here.


Share

COinS